← Leaderboards
Chengyu Liang
Wistar Institute
$16,417,485
Attributed
$16,572,592
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,572,592 · 9
By mechanism
R01$14,502,402 · 5
R21$1,275,443 · 3
U19$794,747 · 1
Top collaborators
- Pinghui Feng2 shared
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingCellsMolecularPathway InteractionsIn VivoGenesGeneticMalignant NeoplasmsAutophagocytosisMutationComplexRegulationInsightPathogenesisTumor Suppressor ProteinsBiochemistryPhysiologicalMultidisciplinarySingle MoleculeMouse ModelProteinsTumorInnovationResistance
Grant awards (46)
Transcriptional Reprogramming in Melanoma Plasticity$594,386
R01 · FY2025 · CA · contact PI
New control of oncogene activation in T-cell leukemia$525,427
R01 · FY2025 · CA · contact PI
Autophagy-mediated defense against inflammation and cancer$434,696
R01 · FY2025 · CA · contact PI
Transcriptional Reprogramming in Melanoma Plasticity$614,911
R01 · FY2024 · CA · contact PI
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC$548,526
R01 · FY2024 · CA · contact PI
New control of oncogene activation in T-cell leukemia$492,814
R01 · FY2024 · CA · contact PI
Autophagy-mediated defense against inflammation and cancer$412,961
R01 · FY2024 · CA · contact PI
Molecular Mechanism of UV Protection in Cutaneous Melanoma$622,335
R01 · FY2023 · ES · contact PI
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC$570,383
R01 · FY2023 · CA · contact PI
New control of oncogene activation in T-cell leukemia$504,152
R01 · FY2023 · CA · contact PI
Autophagy-mediated defense against inflammation and cancer$434,696
R01 · FY2023 · CA · contact PI
Molecular Mechanism of UV Protection in Cutaneous Melanoma$622,335
R01 · FY2022 · ES · contact PI
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC$565,848
R01 · FY2022 · CA · contact PI
New control of oncogene activation in T-cell leukemia$541,927
R01 · FY2022 · CA · contact PI
Autophagy-mediated defense against inflammation and cancer$426,002
R01 · FY2022 · CA · contact PI
Molecular Mechanism of UV Protection in Cutaneous Melanoma$622,335
R01 · FY2021 · ES · contact PI
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC$577,396
R01 · FY2021 · CA · contact PI
Autophagy-mediated defense against inflammation and cancer$415,844
R01 · FY2021 · CA · contact PI
Molecular Mechanism of UV Protection in Cutaneous Melanoma$439,675
R01 · FY2020 · ES · contact PI
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC$429,989
R01 · FY2020 · CA · contact PI
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC$190,500
R01 · FY2020 · CA · contact PI
Targeting the host NDP kinase to abrogate viral dissemination$136,341
R21 · FY2020 · DE · contact PI
Molecular Mechanism of UV Protection in Cutaneous Melanoma$121,355
R01 · FY2020 · ES · contact PI
Targeting the host NDP kinase to abrogate viral dissemination$62,715
R21 · FY2020 · DE · contact PI
Molecular Mechanism of UV Protection in Cutaneous Melanoma$557,211
R01 · FY2019 · ES · contact PI
Targeting the host NDP kinase to abrogate viral dissemination$247,500
R21 · FY2019 · DE · contact PI
Novel mechanism for UVRAG in genome stability and tumor suppression$217,741
R01 · FY2019 · CA · contact PI
Novel mechanism for UVRAG in genome stability and tumor suppression$124,365
R01 · FY2019 · CA · contact PI
Novel mechanism for UVRAG in genome stability and tumor suppression$399,865
R01 · FY2018 · CA · contact PI
Novel mechanism for UVRAG in genome stability and tumor suppression$352,688
R01 · FY2017 · CA · contact PI
Novel mechanism for UVRAG in genome stability and tumor suppression$352,688
R01 · FY2016 · CA · contact PI
Novel mechanism for UVRAG in genome stability and tumor suppression$319,952
R01 · FY2015 · CA · contact PI
Role of UVRAG-mediated Autophagy in Tumor Suppression$275,852
R01 · FY2013 · CA · contact PI
Imaging Core$134,993
U19 · FY2013 · AI · contact PI
Role of UVRAG-mediated Autophagy in Tumor Suppression$293,460
R01 · FY2012 · CA · contact PI
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia$176,175
R21 · FY2012 · CA · contact PI
Imaging Core$143,032
U19 · FY2012 · AI · contact PI
Role of UVRAG-mediated Autophagy in Tumor Suppression$293,460
R01 · FY2011 · CA · contact PI
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia$207,634
R21 · FY2011 · CA · contact PI
Imaging Core$168,949
U19 · FY2011 · AI · contact PI
Role of UVRAG-mediated Autophagy in Tumor Suppression$302,535
R01 · FY2010 · CA · contact PI
Immune Evasion of Autophagy in Gamma-Herpesviruses infection$200,578
R21 · FY2010 · AI · contact PI
Imaging Core$169,450
U19 · FY2010 · AI · contact PI
Role of UVRAG-mediated Autophagy in Tumor Suppression$304,092
R01 · FY2009 · CA · contact PI
Immune Evasion of Autophagy in Gamma-Herpesviruses infection$244,500
R21 · FY2009 · AI · contact PI
Imaging Core$178,323
U19 · FY2009 · AI · contact PI